sponsored
PatientsVille.com Logo

PatientsVille

Flagyl and Loratadine

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectFlagylLoratadine
DRUG INEFFECTIVE2.4% 4.2%
DIARRHOEA3.5% 2.5%
NAUSEA3.4% 3.1%
DRUG HYPERSENSITIVITY3.2% 0.6%
FATIGUE1.9% 3.1%
DYSPNOEA2% 2.9%
HEADACHE2% 2.7%
DIZZINESS1.9% 2.7%
VOMITING2.7% 1.8%
PYREXIA2.6% 1.3%
PAIN2.4% 2.2%
ABDOMINAL PAIN2% 0.9%
OFF LABEL USE0.9% 1.9%
MALAISE1.4% 1.7%
ASTHENIA1.5% 1.6%
RASH1.6% 1.5%
ANXIETY1.5% 1.4%
PNEUMONIA1.2% 1.5%
INSOMNIA0.9% 1.5%
PRURITUS1.2% 1.4%
PAIN IN EXTREMITY1.1% 1.4%
DEPRESSION1.1% 1.4%
ARTHRALGIA1.1% 1.4%
FALL0.8% 1.4%
SOMNOLENCE0.6% 1.4%
COUGH0.6% 1.4%
HYPOTENSION1.3% 0.8%
DRUG INTERACTION1.3% 0.7%
ANAEMIA1.3% 0.7%
CONFUSIONAL STATE1.2% 1%
CHEST PAIN0.9% 1.2%
BACK PAIN0.8% 1.2%
SEPSIS1.2% 0.5%
WEIGHT DECREASED1.1% 1.1%
CONDITION AGGRAVATED0.9% 1.1%
PARAESTHESIA1.1% 0.7%
FEELING ABNORMAL0.6% 1.1%
INJURY1.1% 0%
ABDOMINAL PAIN UPPER1% 1%
DECREASED APPETITE1% 0.9%
HYPERTENSION0.8% 1%
CONSTIPATION0.7% 1%
URTICARIA0.7% 1%
DEHYDRATION1% 0.7%
RENAL FAILURE1% 0.6%
THROMBOCYTOPENIA1% 0%
DEATH0.9% 0.9%
HYPERSENSITIVITY0.7% 0.9%
ACUTE KIDNEY INJURY0.9% 0.6%
MUSCLE SPASMS0.6% 0.9%
CLOSTRIDIUM DIFFICILE INFECTION0.9% 0%
DRUG DOSE OMISSION0% 0.9%
ASTHMA0% 0.9%
WEIGHT INCREASED0% 0.9%
HYPOAESTHESIA0.8% 0.8%
URINARY TRACT INFECTION0.8% 0.8%
TREMOR0.6% 0.8%
PULMONARY EMBOLISM0.8% 0.5%
INFECTION0.8% 0%
NEUTROPENIA0.8% 0%
CLOSTRIDIUM DIFFICILE COLITIS0.8% 0%
NEUROPATHY PERIPHERAL0.8% 0%
SINUSITIS0% 0.8%
OEDEMA PERIPHERAL0.7% 0.7%
GAIT DISTURBANCE0.7% 0.7%
ERYTHEMA0.7% 0.6%
MYALGIA0.6% 0.7%
PALPITATIONS0.5% 0.7%
CHILLS0.7% 0.5%
SEPTIC SHOCK0.7% 0%
TACHYCARDIA0.7% 0%
NASOPHARYNGITIS0% 0.7%
BLOOD PRESSURE INCREASED0% 0.7%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.7%
RENAL FAILURE ACUTE0.7% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.7% 0%
HYPERHIDROSIS0% 0.7%
DEEP VEIN THROMBOSIS0.7% 0%
RESPIRATORY FAILURE0.7% 0%
PATHOGEN RESISTANCE0.7% 0%
GASTROINTESTINAL HAEMORRHAGE0.6% 0.6%
ABDOMINAL DISCOMFORT0.5% 0.6%
SYNCOPE0.5% 0.6%
HAEMOGLOBIN DECREASED0.6% 0.5%
ATRIAL FIBRILLATION0.6% 0.5%
PERIPHERAL SWELLING0% 0.6%
CEREBROVASCULAR ACCIDENT0% 0.6%
ALOPECIA0% 0.6%
MYOCARDIAL INFARCTION0% 0.6%
CHEST DISCOMFORT0% 0.6%
LOSS OF CONSCIOUSNESS0% 0.6%
TOXICITY TO VARIOUS AGENTS0.6% 0%
DRY MOUTH0% 0.6%
COLITIS0.6% 0%
CROHN^S DISEASE0.6% 0%
EMOTIONAL DISTRESS0.6% 0%
DYSGEUSIA0.6% 0%
PANCYTOPENIA0.6% 0%
DYSPHAGIA0.6% 0%
ALANINE AMINOTRANSFERASE INCREASED0.6% 0%
PLEURAL EFFUSION0.6% 0%
ABDOMINAL DISTENSION0.6% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0% 0.6%
DIVERTICULITIS0.6% 0%
HAEMORRHAGE0.6% 0%
VISION BLURRED0% 0.6%
CHRONIC KIDNEY DISEASE0% 0.6%
OVERDOSE0% 0.6%
MEMORY IMPAIRMENT0% 0.6%
INCORRECT DOSE ADMINISTERED0% 0.6%
MUSCULAR WEAKNESS0.5% 0.5%
PRODUCT USE ISSUE0% 0.5%
OROPHARYNGEAL PAIN0% 0.5%
EXPIRED PRODUCT ADMINISTERED0% 0.5%
DYSPEPSIA0% 0.5%
SUICIDAL IDEATION0% 0.5%
SWELLING FACE0% 0.5%
BALANCE DISORDER0% 0.5%
BRONCHITIS0% 0.5%
PRODUCT QUALITY ISSUE0% 0.5%
EPISTAXIS0% 0.5%
INJECTION SITE PAIN0% 0.5%
CARDIAC ARREST0.5% 0%
BLOOD GLUCOSE INCREASED0% 0.5%
FLUSHING0% 0.5%
HEART RATE INCREASED0% 0.5%
HYPOKALAEMIA0.5% 0%
FEBRILE NEUTROPENIA0.5% 0%
ENCEPHALOPATHY0.5% 0%
CHOLELITHIASIS0.5% 0%
ANAPHYLACTIC REACTION0.5% 0%
DYSARTHRIA0.5% 0%
ASPARTATE AMINOTRANSFERASE INCREASED0.5% 0%
TOXIC ENCEPHALOPATHY0.5% 0%
INTERNATIONAL NORMALISED RATIO INCREASED0.5% 0%
WHEEZING0% 0.4%

New treatments are found every day. View current Flagyl research studies and Loratadine clinical trials

1